No CDC Level 4 Travel Health Notices currently exist, supporting the 76.5% market-implied probability against issuance by year-end. Official CDC monitoring as of early June 2026 confirms zero destinations qualify for the highest tier, reserved for extreme risks where no effective precautions exist and humanitarian travel alone is advised. Ongoing Level 2–3 notices address contained outbreaks such as Ebola Bundibugyo in the Democratic Republic of the Congo and Uganda, chikungunya in French Guiana, and dengue or malaria clusters elsewhere, with transmission dynamics limited by available mitigation measures and surveillance. Historical patterns show Level 4 declarations require rapid escalation beyond typical seasonal or regional threats, and no such developments have emerged in recent model runs or case reports.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于是
$71,851 交易量
$71,851 交易量
2026-12-31
是
$71,851 交易量
$71,851 交易量
2026-12-31
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No CDC Level 4 Travel Health Notices currently exist, supporting the 76.5% market-implied probability against issuance by year-end. Official CDC monitoring as of early June 2026 confirms zero destinations qualify for the highest tier, reserved for extreme risks where no effective precautions exist and humanitarian travel alone is advised. Ongoing Level 2–3 notices address contained outbreaks such as Ebola Bundibugyo in the Democratic Republic of the Congo and Uganda, chikungunya in French Guiana, and dengue or malaria clusters elsewhere, with transmission dynamics limited by available mitigation measures and surveillance. Historical patterns show Level 4 declarations require rapid escalation beyond typical seasonal or regional threats, and no such developments have emerged in recent model runs or case reports.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
市场开放时间： Jan 19, 2026, 3:15 PM ET
交易量
$71,851结束日期
2026-12-31市场开放时间
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No CDC Level 4 Travel Health Notices currently exist, supporting the 76.5% market-implied probability against issuance by year-end. Official CDC monitoring as of early June 2026 confirms zero destinations qualify for the highest tier, reserved for extreme risks where no effective precautions exist and humanitarian travel alone is advised. Ongoing Level 2–3 notices address contained outbreaks such as Ebola Bundibugyo in the Democratic Republic of the Congo and Uganda, chikungunya in French Guiana, and dengue or malaria clusters elsewhere, with transmission dynamics limited by available mitigation measures and surveillance. Historical patterns show Level 4 declarations require rapid escalation beyond typical seasonal or regional threats, and no such developments have emerged in recent model runs or case reports.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
交易量
$71,851结束日期
2026-12-31市场开放时间
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...No CDC Level 4 Travel Health Notices currently exist, supporting the 76.5% market-implied probability against issuance by year-end. Official CDC monitoring as of early June 2026 confirms zero destinations qualify for the highest tier, reserved for extreme risks where no effective precautions exist and humanitarian travel alone is advised. Ongoing Level 2–3 notices address contained outbreaks such as Ebola Bundibugyo in the Democratic Republic of the Congo and Uganda, chikungunya in French Guiana, and dengue or malaria clusters elsewhere, with transmission dynamics limited by available mitigation measures and surveillance. Historical patterns show Level 4 declarations require rapid escalation beyond typical seasonal or regional threats, and no such developments have emerged in recent model runs or case reports.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题